BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29130679)

  • 1. 681 Progress report on the elimination of human onchocerciasis, 2016–2017.
    Wkly Epidemiol Rec; 2017 Nov; 92(45):681-94. PubMed ID: 29130679
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Guatemala.
    Wkly Epidemiol Rec; 2016 Oct; 91(43):501-5. PubMed ID: 27801556
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress report on the elimination of human onchocerciasis, 2015-2016.
    Wkly Epidemiol Rec; 2016 Oct; 91(43):505-14. PubMed ID: 27801998
    [No Abstract]   [Full Text] [Related]  

  • 4. African Programme for Onchocerciasis Control: progress report, 2014–2015.
    Wkly Epidemiol Rec; 2015 Dec; 90(49):661-74. PubMed ID: 26638222
    [No Abstract]   [Full Text] [Related]  

  • 5. African Programme for Onchocerciasis Control: progress report, 2013-2014.
    Wkly Epidemiol Rec; 2014 Dec; 89(49):551-60. PubMed ID: 25485343
    [No Abstract]   [Full Text] [Related]  

  • 6. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: elimination of transmission in the north-east focus of the Bolivarian Republic of Venezuela.
    Wkly Epidemiol Rec; 2017 Oct; 92(41):617-23. PubMed ID: 29028167
    [No Abstract]   [Full Text] [Related]  

  • 7. Onchocerciasis and lymphatic filariasis elimination in Africa: it's about time.
    Evans DS; Unnasch TR; Richards FO
    Lancet; 2015 May; 385(9983):2151-2. PubMed ID: 26068266
    [No Abstract]   [Full Text] [Related]  

  • 8. Global programme to eliminate lymphatic filariasis: progress report, 2016.
    Wkly Epidemiol Rec; 2017 Oct; 92(40):594-607. PubMed ID: 28984121
    [No Abstract]   [Full Text] [Related]  

  • 9. Elimination of onchocerciasis in the WHO Region of the Americas: Ecuador’s progress towards verification of elimination.
    Wkly Epidemiol Rec; 2014 Sep; 89(37):401-5. PubMed ID: 25221799
    [No Abstract]   [Full Text] [Related]  

  • 10. Scientists celebrate successes, new tools in fight against human parasitic worms.
    Kuehn BM
    JAMA; 2013 Jul; 310(1):19-20. PubMed ID: 23821071
    [No Abstract]   [Full Text] [Related]  

  • 11. More Progress in Eliminating Transmission of Onchocerca volvulus and Wuchereria bancrofti in the Americas: A Portent of Global Eradication.
    Kazura JW
    Am J Trop Med Hyg; 2015 Dec; 93(6):1128-1129. PubMed ID: 26503272
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress toward elimination of onchocerciasis in the Americas.
    Sauerbrey M; Rakers LJ; Richards FO
    Int Health; 2018 Mar; 10(suppl_1):i71-i78. PubMed ID: 29471334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onchocerciasis in Yemen: Time to take action against a neglected tropical parasitic disease.
    Abdul-Ghani R; Mahdy MAK; Beier JC
    Acta Trop; 2016 Oct; 162():133-141. PubMed ID: 27325293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-border collaboration for neglected tropical disease efforts-Lessons learned from onchocerciasis control and elimination in the Mano River Union (West Africa).
    Gustavsen K; Sodahlon Y; Bush S
    Global Health; 2016 Aug; 12(1):44. PubMed ID: 27549911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic impacts of elimination of onchocerciasis in Abu-Hamed focus, northern Sudan: lessons after elimination.
    Ahmed A; Elbashir A; Mohamed AA; Alim AA; Mubarak A; Abdelrahman D; Mohammed E; Mohamed NS; Elaagip AH; Zarroug IMA; Mounkaila N; Tahir H
    BMC Res Notes; 2020 May; 13(1):256. PubMed ID: 32456708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new key-player for onchocerciasis elimination.
    Jesudason T
    Lancet Infect Dis; 2023 Apr; 23(4):413. PubMed ID: 36965498
    [No Abstract]   [Full Text] [Related]  

  • 17. Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa.
    Turner HC; Walker M; Churcher TS; Osei-Atweneboana MY; Biritwum NK; Hopkins A; Prichard RK; Basáñez MG
    Clin Infect Dis; 2014 Oct; 59(7):923-32. PubMed ID: 24944228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onchocerciasis: shifting the target from control to elimination requires a new first-step-elimination mapping.
    Rebollo MP; Zoure H; Ogoussan K; Sodahlon Y; Ottesen EA; Cantey PT
    Int Health; 2018 Mar; 10(suppl_1):i14-i19. PubMed ID: 29471341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ending lymphatic filariasis and onchocerciasis in Africa: Reasons for hope.
    Masiyiwa T; Bockarie MJ
    Int J Infect Dis; 2024 Mar; 140():102-103. PubMed ID: 38280664
    [No Abstract]   [Full Text] [Related]  

  • 20. From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.
    Colebunders R; Siewe Fodjo JN; Hopkins A; Hotterbeekx A; Lakwo TL; Kalinga A; Logora MY; Basáñez MG
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007407. PubMed ID: 31318857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.